Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Eli Lilly Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (76)
Cancellation by sponsor (55)
Australian Public Assessment Report (AusPAR) (19)
Prescription medicine registration (16)
Designation or determination (4)
Prescription medicine decision summary (3)
Prescription medicine evaluation (3)

Date

2024 (23)
2023 (22)
2022 (15)
2021 (10)
2020 (4)
2019 (34)
2018 (14)
2017 (1)
2016 (2)
2015 (7)
2014 (2)
2013 (4)
2012 (1)
2011 (2)
2010 (1)
2008 (4)
2007 (3)
2006 (1)
2004 (7)
2003 (1)
2002 (2)
1999 (5)
1998 (1)
1996 (2)
1993 (1)
1992 (4)
1991 (3)

Results for "[search-keyword]"

Search

Sponsor content

176 result(s) found, displaying 91 to 100

LANZEK ZYDIS olanzapine 20mg wafer blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2019

Cancellation by sponsor

Requested by Eli Lilly Australia Pty Ltd
LANZEK olanzapine 2.5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2019

Cancellation by sponsor

Requested by Eli Lilly Australia Pty Ltd
LANZEK olanzapine 5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2019

Cancellation by sponsor

Requested by Eli Lilly Australia Pty Ltd
LANZEK olanzapine 7.5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2019

Cancellation by sponsor

Requested by Eli Lilly Australia Pty Ltd
LANZEK olanzapine 10mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2019

Cancellation by sponsor

Requested by Eli Lilly Australia Pty Ltd
LILLY OLANZAPINE IM olanzapine 10mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

27 June 2019

Cancellation by sponsor

Requested by Eli Lilly Australia Pty Ltd
OLANZAPINE LY olanzapine 10mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Eli Lilly Australia Pty Ltd
OLANZAPINE LY IM olanzapine 10mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Eli Lilly Australia Pty Ltd
OLANZAPINE LY WAFER olanzapine 10mg wafer blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Eli Lilly Australia Pty Ltd
RALOXIFENE LY raloxifene hydrochloride 60mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Eli Lilly Australia Pty Ltd

Pages

First page
Previous page
…
Page 6
Page 7
Page 8
Page 9
Current page 10
Page 11
Page 12
Page 13
Page 14
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.